APDA Information and Referral Center
Call for appointment:410-328-4323 410-328-4323
The Parkinson's Disease Information and Referral Center located at the Maryland Parkinson’s Disease and Movement Disorders Center provides educational and emotional support to Parkinson's disease patients and their families.
Established in 1980, the center provides:
- Info and resources about PD to patients, families, healthcare professionals, students and the community
- Referrals to neurologists, movement disorder specialists, rehabilitation specialists (physical and occupational therapists, speech language pathologists), respite programs, community agencies, research centers and more
- Distribution of literature from the APDA and materials from the Parkinson's Center lending library
- Educational programs
- Help in establishing and maintaining support groups
The Medical Director of the APDA Information & Referral Center is Dr. Lisa Shulman. The coordinator is Michelle Cines, RN, MS.
The American Parkinson Disease Association (APDA) is the largest grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to assist the more than 1 million Americans with PD live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $170 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease.
To join us in the fight against Parkinson’s disease and to learn more about the support APDA provides nationally through our network of Chapters and Information & Referral (I&R) Centers, as well as our national Research Program and Centers for Advanced Research, please visit us at apdaparkinson.org
Parkinson's disease affects more than 1 million people in the United States annually, with at least 65,000 new cases diagnosed each year. The chronic and progressive neurological condition is the second most common neurodegenerative aging disorder, after Alzheimer's disease.
For more information, contact:
Christina Griffin, MS